Patents Assigned to Bayer Health Care
-
Publication number: 20100248384Abstract: An optical waveguiding optical format enables consistent optical analysis of small sample volumes with minimal variation in light path length among optical formats. The optical format is comprised of an input guide, an output guide, and a sample cavity adapted to allow light to pass through a sample on its way from the input guide to the output guide. A lid removed from the light pathway within the format may be provided with a reagent for assisting fluid analysis.Type: ApplicationFiled: May 7, 2010Publication date: September 30, 2010Applicant: Bayer Health Care, LLCInventor: Allen J. Brenneman
-
Publication number: 20100113897Abstract: A continuous analyte monitoring assembly is adapted to assist in determining an analyte level of a fluid. The monitoring assembly includes a housing, electronics, an implantable sensor and a cannula. The housing has a bottom in which the bottom forms a recess. The electronics are located within the housing and assist in determining an analyte level of a fluid sample. The sensor moves from a retracted position to an inserted position using the recess. The cannula assists in placing the implantable sensor.Type: ApplicationFiled: March 14, 2008Publication date: May 6, 2010Applicant: Bayer Health Care LLCInventors: Allen J. Brenneman, James E. Smous
-
Publication number: 20090298822Abstract: The present invention relates to the use of compounds for manufacturing a pharmaceutical product/medicament for the prophylaxis and/or treatment of reperfusion damage.Type: ApplicationFiled: July 6, 2006Publication date: December 3, 2009Applicant: Bayer Health CareInventors: Thomas Krahn, Johannes-peter Stasch, Gerrit Weimann, Wolfgang Thielemann
-
Patent number: 7598056Abstract: Conjugates of Factor VII (FVII) and Factor VIIa (FVIIA) are provided, as are methods for preparing them. Methods for producing novel polypeptides contributing to the production of such conjugates are provided. Methods of treatment by administering a FVII or FVIIa conjugate are provided.Type: GrantFiled: April 18, 2006Date of Patent: October 6, 2009Assignee: Bayer Health Care LLCInventors: Anders Hjelholt Pedersen, Kim Vilbour Andersen, Claes Bornaes
-
Publication number: 20070259834Abstract: The present invention relates to dermally applicable liquid formulations comprising synthetic or natural pyrethroids and halogen-free guanidines for controlling parasitic arthropods on animals.Type: ApplicationFiled: April 18, 2005Publication date: November 8, 2007Applicant: BAYER HEALTH CARE AGInventors: Kirkor Sirinyan, Andreas Turberg, Thomas Bach
-
Publication number: 20070129355Abstract: The present invention relates to a pyrimidine derivative of the formula (I) and salts thereof which is useful as an active ingredient of pharmaceutical preparations. The pyrimidine derivative of the present invention has excellent CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity and can be used for the prophylaxis and treatment of diseases associated with CRTH2 activity, in particular for the treatment of allergic diseases, such as asthma, allergic rhinitis, atopic dermatitis, and allergic conjunctivitis; eosinophil-related diseases, such as Churg-Strauss syndrome and sinusitis; basophil-related diseases, such as basophilic leukemia, chronic urticaria and basophilic leukocytosis in human and other mammals; and inflammatory diseases characterized by T lymphocytes and profuse leukocyte infiltrates such as psoriasis, eczema, inflammatory bowel disease, ulcerative colitis, Crohn's disease, COPD (chronic obstructive pulmonary disorder) and arthritis.Type: ApplicationFiled: April 14, 2004Publication date: June 7, 2007Applicants: ACTIMIS PHARMACEUTICALS, INC., BAYER AG, BAYER HEALTH CARE AGInventors: Tai-wei Ly, Yuji Koriyama, Takashi Yoshino, Hiroki Sato, Kazuho Tanaka, Hiromi Sugimoto, Yoshihisa Manabe, Kevin Bacon, Klaus Urbahns, Masanori Seki, Takuya Shintani
-
Patent number: 7214538Abstract: The present invention relates to a novel device and method for the detection of lithium ions in a biological fluid. In a preferred embodiment, the present invention provides a novel compound and a optical sensor which incorporates said compound for the detection of lithium ions. Additionally, the present invention provides a method of detecting lithium ions which comprises placing the novel optical sensor into communication with a biological fluid. Once the novel compound of the present invention encounters a lithium ion(s), a fluorescence is generated, the intensity of which is measured and allows for the determination of lithium ion concentration. The present invention provides a medical professional with the ability to selectively determine lithium ion concentration in a biological fluid thereby facilitating the treatment of various diseases, such as manic-depressive illness.Type: GrantFiled: February 11, 2004Date of Patent: May 8, 2007Assignees: Worcester Polytechnic Institute, Bayer Health Care, LLC.Inventors: John S. Benco, Hubert A. Nienaber, W. Grant McGimpsey
-
Publication number: 20060236766Abstract: An ultrasonic beam shaping device includes a plate-like beam shaping element formed of opaque material. The beam shaping element has first and second conical surfaces, with a common axis, formed as opposite surface portions of the beam shaping element. A cylindrical aperture is formed in the beam shaping element along the common axis of the first and second conical surfaces such that the cylindrical aperture is also co-axial with the conical surfaces and passes through the conical surfaces. The beam shaping element thus has a circular open end at each conical surface.Type: ApplicationFiled: February 11, 2005Publication date: October 26, 2006Applicant: BAYER HEALTH CARE LLCInventors: Jo-Ana Quirch, Nicolae Dumitrescu, Luigi Cantatore
-
Publication number: 20060211655Abstract: The present invention relates to the use of an arthropod-repelling component from the pyrethroid/pyrethrin class in combination with an agonist of the nicotinergic acetylcholine receptors of arthropods for repelling arthropods, preferably on animals, in an effective and sustainable manner.Type: ApplicationFiled: January 5, 2004Publication date: September 21, 2006Applicant: Bayer Health Care agInventors: Norbert Mencke, Dorothee Stanneck, Andreas Turberg, Hans Dautel